The IHC score results showed that the expression level of CYP2U1 in breast carcinoma specimen with pathological grade 3 is higher than that in breast cancer tissues with pathological grade 1–2 (P = 0.0008) (Figure 2B). This evidence concerns the gene CYP2U1 and breast cancer.